Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Drugs
Drugs
Page 28 of 30
Tech
Drugmaker Alexion boosts its rare drug pipeline with $8.4 billion deal
By
Reuters
May 6, 2015
Finance
Mylan goes big with $29 billion offer to buy Perrigo
By
Laura Lorenzetti
April 8, 2015
Retail
States ask U.S. Congress to launch inquiry of herbal supplements
By
Reuters
April 2, 2015
International
Takeda’s ready to shell out $2.2 billion to settle Actos drug cases
By
Laura Lorenzetti
April 1, 2015
Leadership
Where do CEOs with addictions go when they hit bottom?
By
Daniel Bukszpan
March 25, 2015
Features
Merck halts study in light of melanoma drug’s success
By
Laura Lorenzetti
March 24, 2015
Features
How Biogen scored the most successful Alzheimer’s drug so far
By
Jen Wieczner
March 21, 2015
Finance
Valeant comes out a winner after upping its Salix bid to $11.1 billion
By
Laura Lorenzetti
March 16, 2015
Features
FDA approves the first biosimilar for the U.S. market
By
Laura Lorenzetti
March 6, 2015
Finance
AbbVie to buy cancer drug maker Pharmacyclics in $21 billion deal
By
Reuters
March 5, 2015
Retail
Rite Aid takes aim at CVS with a $2 billion purchase
By
Laura Lorenzetti
February 11, 2015
Features
Biosimilars may one day save your life. But what are they?
By
Laura Lorenzetti
February 6, 2015
Finance
After Allergan loss, is Valeant dumpster diving?
By
Jen Wieczner
January 31, 2015
How to stop generic drug shortages: end hospital group purchasing kickbacks
By
Phillip L. Zweig
and
Robert A. Campbell
January 30, 2015
Report predicts 18 states will legalize pot by 2020
By
TIME
January 26, 2015
Most Popular
AI
A man let ChatGPT sell his home. It beat every agent's estimate by $100K—and closed in 5 days
By
Jake Angelo
Success
Covid gave us hybrid work. The Iran War might give us a four-day week—and this time, experts say it could stick
By
Orianna Rosa Royle
Real Estate
Gen Z can’t afford a house. Some parents are choosing to fund their down payments over their college funds
By
Jake Angelo